RE:RE:RE:The reason no analysts took Thera seriously Lots of respect for all of you on this board, even with those I dont share the same opinion,
But the point here, as An-Alias said yesterday, as nothing to do with Montreal-Canada-Boston-U.S.
But, and I said that here before the earning call: IF they dont give a clear guidance that NASH is on track than the market will be fragile to give TH\THERF a "go to the next step stock wise". So, the next target, lets say: 8$US share price.....
It will come, but it takes a time after the PROCEED LETTER that is giving the shorts the momemtum, not the longs.
It will come.
And than, another "we have turned the corner, and the second curve" will occur.
May ? June ?.....its just there.....
And lets keep the eyes on the real objective: DECEMBER 2021.......if good result in oncology, we will all be in favor and position to cash a nice family vacation because we were patient enough to believe in those words from the new CEO: "Theratechnologies is at a unique point in its evolution, and we have a tremendous opportunity ahead of us,” said Paul Levesque, President and Chief Executive Officer at Theratechnologies. “We are particularly pleased with the swift advancement of our Phase 1 oncology program, which has dosed its first patient, and the continued progress we have made toward advancing our Phase 3 trial in NASH "
FTV.